DPDoctor's PassportEducation
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMLAMSRAGP

Cellulitis and erysipelas

Essential points for quick revision.

!
Disproportionate pain may signal necrotising infection

Rapid progression, severe pain beyond visible change, crepitus, bullae, skin anaesthesia, necrosis or systemic shock is not uncomplicated cellulitis.

Action: Start ABCDE and sepsis care, obtain immediate surgical review and give broad intravenous antimicrobials without delaying operative source control for imaging.

Synopsis

Recognise acute bacterial skin and soft-tissue infection, exclude common mimics and limb-threatening disease, choose oral or intravenous antibiotics by severity and review response within the expected trajectory.

  • Cellulitis is an acute, usually unilateral, tender warm expanding infection of dermis and subcutis; erysipelas is more superficial, raised and sharply demarcated.
  • Mark the edge with date and time when appropriate, but judge deterioration by physiology, pain, function and new features as well as millimetres of redness.
  • Exclude an abscess, necrotising infection, septic joint, orbital disease and common non-infective mimics before issuing routine oral antibiotics.

Key red flags

Sepsis physiology, necrotising features, orbital or facial danger-site infection, compartment syndrome, septic joint, osteomyelitis, severe immunocompromise, rapidly spreading disease or inability to take oral treatment requires hospital assessment.

Necrotising departure

Pain out of proportion, rapid spread, skin anaesthesia, crepitus, haemorrhagic bullae, necrosis or shock demands immediate surgery.

Investigation priorities

01
ABCDE and sepsis assessmentFirst step

Identify systemic severity and determine hospital or intravenous-treatment need.

Management branches

Uncomplicated outpatientStart narrow oral treatment

Cellulitis is localised, the patient is stable, oral treatment is feasible and no danger-site or unusual exposure applies.

  1. Mark and document extent, portal, pain and observations, then start oral flucloxacillin for five to seven days after allergy assessment.
  2. Advise elevation, fluids, analgesia and treatment of toe-web fungal disease, eczema or wounds while avoiding compression during intolerable acute pain.

Key medicines

Flucloxacillin capsulesTake 500 mg to 1 g orally four times daily for five to seven days for uncomplicated adult cellulitis.
Clarithromycin tabletsTake 500 mg orally twice daily for five to seven days when a true penicillin allergy makes it appropriate.
Open full textbook Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom